Cargando…

Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023

Detalles Bibliográficos
Autores principales:	Hause, Anne M., Marquez, Paige, Zhang, Bicheng, Moro, Pedro L., Myers, Tanya R., Bradley, Colin, Bazel, Samaneh, Panchanathan, Sarada S., Shimabukuro, Tom T., Shay, David K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328461/ https://www.ncbi.nlm.nih.gov/pubmed/37289661 http://dx.doi.org/10.15585/mmwr.mm7223a2

Ejemplares similares

COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system
por: Chapin-Bardales, Johanna, et al.
Publicado: (2021)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022
por: Moro, Pedro L., et al.
Publicado: (2023)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
por: Rosenblum, Hannah G, et al.
Publicado: (2022)

Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023
por: Romanson, Brittney, et al.
Publicado: (2023)

Progress Toward Poliomyelitis Eradication — Pakistan, January 2022–June 2023
por: Mbaeyi, Chukwuma, et al.
Publicado: (2023)

Progress Toward Eradication of Dracunculiasis — Worldwide, January 2022–June 2023
por: Hopkins, Donald R., et al.
Publicado: (2023)

Progress Toward Poliomyelitis Eradication — Afghanistan, January 2022–June 2023
por: Bjork, Adam, et al.
Publicado: (2023)

Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study
por: Wong, Karen K, et al.
Publicado: (2022)

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults
por: Tompkins, Lindsay K., et al.
Publicado: (2022)

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
por: Shay, David K., et al.
Publicado: (2021)

51-June 2023
Publicado: (2023)

June 2023 obituaries
Publicado: (2023)

CMS Week June 2023
por: Hurst, Sofia, et al.
Publicado: (2023)

May/June 2023 Forum
Publicado: (2023)

Editors’ Message – June 2023
por: Michos, Erin D., et al.
Publicado: (2023)

Evaluation of the pilot wastewater surveillance for SARS-CoV-2 in Norway, June 2022 – March 2023
por: Amato, Ettore, et al.
Publicado: (2023)

Epilepsia Open—June 2023—Announcements
Publicado: (2023)

Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023
por: Ford, Nicole D., et al.
Publicado: (2023)

Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
por: Hause, Anne M., et al.
Publicado: (2021)

The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response
por: Myers, Tanya R., et al.
Publicado: (2023)

Increased reports of severe myocarditis associated with enterovirus infection in neonates, United Kingdom, 27 June 2022 to 26 April 2023
por: Singanayagam, Anika, et al.
Publicado: (2023)

Avian influenza overview June–September 2023
por: Adlhoch, Cornelia, et al.
Publicado: (2023)

Avian influenza overview April – June 2023
por: Adlhoch, Cornelia, et al.
Publicado: (2023)

Human vaccines & immunotherapeutics: News June 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

Jahresrückblick 2022 – Jahresausblick 2023
por: Kerbl, Reinhold
Publicado: (2022)

Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022
por: Duffy, Jonathan, et al.
Publicado: (2022)

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
por: Shimabukuro, Tom T., et al.
Publicado: (2021)

Top Quarks + X Summary Plots June 2023
por: The ATLAS collaboration
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_78821ga0msdhs8sdv0l140c33q